Through the Collaboration, Nyrada has greater access to funding opportunities (such as research grants) to advance our brain injury program that will not require additional Nyrada shares to be issued, thereby not diluting existing shareholder interests in the Company.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $62.37M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 28.0¢ | $277.0K | 957.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 116270 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 130414 | 1 |
View Market Depth
| Last trade - 15.54pm 07/08/2025 (20 minute delay) ? |
| NYR (ASX) Chart |